MiMedx favorable ruling on product's regulatory classification

 

U.S. court vacates FDA decision on MiMedx's AXIOFILL, orders agency to reconsider product's regulatory classification

• Ruling vacates FDA findings that AXIOFILL is not minimally manipulated and should be regulated as a biological product.

https://finviz.com/stock?t=MDXG&p=d